Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells
The cellular origin and oncogenic drivers promoting claudin-low breast cancer are undefined. Here, the authors report that the consistent activation of oncogenic RAS signaling, as well as regulators of EMT, play a crucial role in the cellular plasticity and maintenance of the mesenchymal and stem ce...
Guardado en:
Autores principales: | Patrick D. Rädler, Barbara L. Wehde, Aleata A. Triplett, Hridaya Shrestha, Jonathan H. Shepherd, Adam D. Pfefferle, Hallgeir Rui, Robert D. Cardiff, Charles M. Perou, Kay-Uwe Wagner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/73b3b931199c4ef2944a84166e09403e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Stat3 is required to maintain the full differentiation potential of mammary stem cells and the proliferative potential of mammary luminal progenitors.
por: Anna D Staniszewska, et al.
Publicado: (2012) -
TET2 directs mammary luminal cell differentiation and endocrine response
por: Mi Ran Kim, et al.
Publicado: (2020) -
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression
por: Veronica Giusti, et al.
Publicado: (2021) -
Regulation of claudin/zonula occludens-1 complexes by hetero-claudin interactions
por: Barbara Schlingmann, et al.
Publicado: (2016) -
Induced p53 loss in mouse luminal cells causes clonal expansion and development of mammary tumours
por: Luwei Tao, et al.
Publicado: (2017)